Sort
48,018 grants matching “immunotherapy”
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
$570,505Jarrod Dudakov · Fred Hutchinson Cancer Center · R01 · FY2023 · HL
Lung-brain coupling and the immune response to acute ischemic stroke
$570,449Marc W Halterman · State University New York Stony Brook · R01 · FY2022 · NS
Targeting cancer neoantigens in patients with myeloid malignancies
$570,422Vid Leko · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
$570,401Jing Hong Wang · University Of Colorado Denver · R01 · FY2020 · DE
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$570,320Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Study interactions between lung microbiota and immune cells in NSCLC
$570,287Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$570,252Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$570,216Manish Bais · Boston University Medical Campus · R01 · FY2022 · DE
Development and Evaluation of Advanced Non-Contrast Perfusion MRI for Monitoring Treatment Response in Brain Metastases
$570,211Qin Qin · University Of Washington · R01 · FY2025 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
$570,144Mary L. Disis · University Of Washington · R01 · FY2014 · CA
PD-1/PD-L1 modulation in cancer therapy
$570,133Drew M. Pardoll · Johns Hopkins University · R01 · FY2024 · CA
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$570,097Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2019 · HL
Chemo-radio immunotherapy for pediatric brain tumors
$570,066David H Munn · Augusta University · R01 · FY2023 · CA
Chemo-radio immunotherapy for pediatric brain tumors
$570,066David H Munn · Augusta University · R01 · FY2022 · CA
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$570,059Kara Lynn Davis · Stanford University · R01 · FY2025 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$570,048Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2024 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2018 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2020 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2021 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2017 · CA
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
$569,928Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2020 · CA
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
$569,907David M. Lewinsohn · Oregon Health & Science University · R01 · FY2021 · AI
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$569,902Adam I Marcus · Emory University · P01 · FY2023 · CA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$569,842John H Sampson · Duke University · U01 · FY2015 · NS
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases
$569,792James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2016 · DK